Noice_老虎社区_美港股上老虎

Lzqqzl
2021-10-28

Noice

Teladoc Health Stock Gains After Q3 Results, Clocks 81% Top-Line Growth<blockquote>Teladoc Health股票在第三季度业绩公布后上涨，营收增长81%</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":854883621,"tweetId":"854883621","gmtCreate":1635432719597,"gmtModify":1635432719782,"author":{"id":3582002752317067,"idStr":"3582002752317067","authorId":3582002752317067,"authorIdStr":"3582002752317067","name":"Lzqqzl","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Noice</p></body></html>","htmlText":"<html><head></head><body><p>Noice</p></body></html>","text":"Noice","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/854883621","repostId":2178267992,"repostType":4,"repost":{"id":"2178267992","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1635432578,"share":"https://www.laohu8.com/m/news/2178267992?lang=zh_CN&edition=full","pubTime":"2021-10-28 22:49","market":"us","language":"en","title":"Teladoc Health Stock Gains After Q3 Results, Clocks 81% Top-Line Growth<blockquote>Teladoc Health股票在第三季度业绩公布后上涨，营收增长81%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2178267992","media":"Benzinga","summary":"\n","content":"<p><ul>  <li><b>Teladoc Health Inc&nbsp;</b>(NYSE:TDOC)&nbsp;posted a narrower than expected Q3 EPS loss of $(0.53)&nbsp;versus consensus of $(0.65), though loss widened when compared to $(0.43) reported a year ago.</li>  <li>Q3 net loss included a stock-based compensation expense of $71.7 million, reflecting Livongo stock awards.</li>  <li>Teladoc managed to grow its top line by 81% to $521.66 million, beating the consensus of $516.63 million.</li>  <li>During the quarter, the company saw visits jump to 3.9 million, +37% Y/Y,</li>  <li>Paid memberships in the U.S. were 52.5 million, up 2% Y/Y.</li>  <li>The average revenue per member per month was $2.57, up from $1.18 last year and $2.47 in 2Q21, the company mentioned in the Q3 earnings conference call.</li>  <li>Adjusted EBITDA was $67.4 million compared to $39.5 million a year ago.</li>  <li><b>FY2021 guidance:&nbsp;</b>Teladoc forecasts sales of $2.015 billion - $2.025 billion, with EPS loss of $(3.40) - $(3.20), compared to&nbsp;earlier guidance&nbsp;of $2 billion - $2.025 billion and $(3.60) to $(3.35), respectively.</li>  <li>It anticipates 14.5 million - 14.7 million total visits, with U.S. paid memberships of 52.5 million - 53.5 million.</li>  <li>For Q4, Teladoc sees sales of $536 million - $546 million (consensus $539.74 million), and EPS loss of $(0.73) - $(0.53). It anticipates 3.9 million - 4.1 million total visits for Q4.</li>  <li><b>Price Action:</b>&nbsp;TDOC shares are up 5.68% at $146.50 on the last check Thursday.</li> </ul></p><p><blockquote><ul><li><b>Teladoc健康公司</b>（纽约证券交易所股票代码：TDOC）公布的第三季度每股收益亏损为(0.53)美元，低于预期，而市场普遍预期为(0.65)美元，但与一年前报告的(0.43)美元相比，亏损有所扩大。</li><li>第三季度净亏损包括7170万美元的股票薪酬费用，反映了Livongo股票奖励。</li><li>Teladoc的营收增长了81%，达到5.2166亿美元，超出了市场普遍预期的5.1663亿美元。</li><li>本季度，该公司的访问量跃升至390万人次，同比增长37%，</li><li>美国付费会员数量为5250万，同比增长2%。</li><li>该公司在第三季度财报电话会议中提到，每位会员每月平均收入为2.57美元，高于去年的1.18美元和2021年第二季度的2.47美元。</li><li>调整后EBITDA为6740万美元，而去年同期为3950万美元。</li><li><b>2021财年指引：</b>Teladoc预测销售额为20.15亿美元至20.25亿美元，每股收益损失为(3.40)至(3.20)美元，而之前的指导分别为20亿美元至20.25亿美元和(3.60)至(3.35)美元。</li><li>预计总访问量为1450万至1470万，美国付费会员为5250万至5350万。</li><li>Teladoc预计第四季度销售额为5.36亿美元至5.46亿美元（市场普遍预期为5.3974亿美元），每股收益亏损为(0.73)美元至(0.53)美元。预计第四季度总访问量为390万-410万。</li><li><b>价格走势：</b>周四最后一次检查时，TDOC股价上涨5.68%，至146.50美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teladoc Health Stock Gains After Q3 Results, Clocks 81% Top-Line Growth<blockquote>Teladoc Health股票在第三季度业绩公布后上涨，营收增长81%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeladoc Health Stock Gains After Q3 Results, Clocks 81% Top-Line Growth<blockquote>Teladoc Health股票在第三季度业绩公布后上涨，营收增长81%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-10-28 22:49</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><ul>  <li><b>Teladoc Health Inc&nbsp;</b>(NYSE:TDOC)&nbsp;posted a narrower than expected Q3 EPS loss of $(0.53)&nbsp;versus consensus of $(0.65), though loss widened when compared to $(0.43) reported a year ago.</li>  <li>Q3 net loss included a stock-based compensation expense of $71.7 million, reflecting Livongo stock awards.</li>  <li>Teladoc managed to grow its top line by 81% to $521.66 million, beating the consensus of $516.63 million.</li>  <li>During the quarter, the company saw visits jump to 3.9 million, +37% Y/Y,</li>  <li>Paid memberships in the U.S. were 52.5 million, up 2% Y/Y.</li>  <li>The average revenue per member per month was $2.57, up from $1.18 last year and $2.47 in 2Q21, the company mentioned in the Q3 earnings conference call.</li>  <li>Adjusted EBITDA was $67.4 million compared to $39.5 million a year ago.</li>  <li><b>FY2021 guidance:&nbsp;</b>Teladoc forecasts sales of $2.015 billion - $2.025 billion, with EPS loss of $(3.40) - $(3.20), compared to&nbsp;earlier guidance&nbsp;of $2 billion - $2.025 billion and $(3.60) to $(3.35), respectively.</li>  <li>It anticipates 14.5 million - 14.7 million total visits, with U.S. paid memberships of 52.5 million - 53.5 million.</li>  <li>For Q4, Teladoc sees sales of $536 million - $546 million (consensus $539.74 million), and EPS loss of $(0.73) - $(0.53). It anticipates 3.9 million - 4.1 million total visits for Q4.</li>  <li><b>Price Action:</b>&nbsp;TDOC shares are up 5.68% at $146.50 on the last check Thursday.</li> </ul></p><p><blockquote><ul><li><b>Teladoc健康公司</b>（纽约证券交易所股票代码：TDOC）公布的第三季度每股收益亏损为(0.53)美元，低于预期，而市场普遍预期为(0.65)美元，但与一年前报告的(0.43)美元相比，亏损有所扩大。</li><li>第三季度净亏损包括7170万美元的股票薪酬费用，反映了Livongo股票奖励。</li><li>Teladoc的营收增长了81%，达到5.2166亿美元，超出了市场普遍预期的5.1663亿美元。</li><li>本季度，该公司的访问量跃升至390万人次，同比增长37%，</li><li>美国付费会员数量为5250万，同比增长2%。</li><li>该公司在第三季度财报电话会议中提到，每位会员每月平均收入为2.57美元，高于去年的1.18美元和2021年第二季度的2.47美元。</li><li>调整后EBITDA为6740万美元，而去年同期为3950万美元。</li><li><b>2021财年指引：</b>Teladoc预测销售额为20.15亿美元至20.25亿美元，每股收益损失为(3.40)至(3.20)美元，而之前的指导分别为20亿美元至20.25亿美元和(3.60)至(3.35)美元。</li><li>预计总访问量为1450万至1470万，美国付费会员为5250万至5350万。</li><li>Teladoc预计第四季度销售额为5.36亿美元至5.46亿美元（市场普遍预期为5.3974亿美元），每股收益亏损为(0.73)美元至(0.53)美元。预计第四季度总访问量为390万-410万。</li><li><b>价格走势：</b>周四最后一次检查时，TDOC股价上涨5.68%，至146.50美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178267992","content_text":"Teladoc Health Inc (NYSE:TDOC) posted a narrower than expected Q3 EPS loss of $(0.53) versus consensus of $(0.65), though loss widened when compared to $(0.43) reported a year ago.\nQ3 net loss included a stock-based compensation expense of $71.7 million, reflecting Livongo stock awards.\nTeladoc managed to grow its top line by 81% to $521.66 million, beating the consensus of $516.63 million.\nDuring the quarter, the company saw visits jump to 3.9 million, +37% Y/Y,\nPaid memberships in the U.S. were 52.5 million, up 2% Y/Y.\nThe average revenue per member per month was $2.57, up from $1.18 last year and $2.47 in 2Q21, the company mentioned in the Q3 earnings conference call.\nAdjusted EBITDA was $67.4 million compared to $39.5 million a year ago.\nFY2021 guidance: Teladoc forecasts sales of $2.015 billion - $2.025 billion, with EPS loss of $(3.40) - $(3.20), compared to earlier guidance of $2 billion - $2.025 billion and $(3.60) to $(3.35), respectively.\nIt anticipates 14.5 million - 14.7 million total visits, with U.S. paid memberships of 52.5 million - 53.5 million.\nFor Q4, Teladoc sees sales of $536 million - $546 million (consensus $539.74 million), and EPS loss of $(0.73) - $(0.53). It anticipates 3.9 million - 4.1 million total visits for Q4.\nPrice Action: TDOC shares are up 5.68% at $146.50 on the last check Thursday.","news_type":1,"symbols_score_info":{"TDOC":0.9}},"isVote":1,"tweetType":1,"viewCount":1827,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Teladoc Health Stock Gains After Q3 Results, Clocks 81% Top-Line Growth<blockquote>Teladoc Health股票在第三季度业绩公布后上涨，营收增长81%</blockquote>

评论（1）

热议股票